Overzicht Proefschriften

Tips in using the search/filter fields

Tips in using the search/filter fields
Select on a part of the content: ede Select exactly on a certain content: =ede
Select all fields that are NOT empty: >'' (two single quotes) Select all fields that are empty: =[spatie]
Select everything after a certain date: >31-12-2010 Select everything before a certain date: <31-12-2010
Select on a period containing the given date: >31-12-2010<1-2-2011 Type nu in a 'date' field to select everything between yesterday and tomorrow
By clicking a column title the table will be sorted on this column. If you then click the title of another column, the sort will be on this second column, preserving the first sort.
So if you want to sort on City and witghin that on Name, first click teh Name column and after that the City column. Click Reset to reset the filters and sorting.
Filters an sorting are saved and will be restored when you come back to this screen. Click Reset to reset the filters and sorting.
Go to page:
  • of 6

Displaying 1-50 of 278 results.
TitelPromovendusPromotor 1Promotor 2Copromotor 1Copromotor 2UniversiteitPromotiejaarTrefwoorden
Mitochondrial failure in sepsis; Acute mechnisms and long-term consequences. Henning R.H., prof. dr.Bouma H.R., PhDRijksuniversiteit Groningen (RUG)0Mitrochondrial failure in Sepsis
Drug development and new targets for redox disturbances in experimental vascular diseaseHenning R.H., prof. dr.Deelman L.E., dr.Buikema J.H., dr.Rijksuniversiteit Groningen (RUG)2022Drug development, redox disturbance, experimental vascular disease
Learning in a student-run clinic: a new concept to improve medical education in pharmacotherapySchutte T., PhDAgtmael M.A. van, prof. dr.Richir M.C., MD PhDTichelaar J., dr.Vrije Universiteit Amsterdam (VU)2018Pharmacotherapy education; Student-run clinic; Medical education; Workplace learning; Undergraduate education;
Rational prescribing in Europe: are future doctors well prepared?Brinkman D.J., PhDAgtmael M.A. van, prof. dr.Richir M.C., MD PhDTichelaar J., dr.Vrije Universiteit Amsterdam (VU)2018Clinical pharmacology; Pharmacotherapy; Prescribing;
Bioanalysis and biotransformation of tyrosine kinase inhibitors in oncologyRood J.J.M., PhDBeijnen J.H., prof. dr.Sparidans R.W., dr.Universiteit Utrecht (UU)2019
Towards better fall prevention - examining the interplay between factors that influence gait in older patientsGroot M.H. de, PhDBeijnen J.H., prof. dr.Lamoth C.J.C., dr.Universiteit Utrecht (UU)2017Falls; Gait analysis; Accelerometry; Frailty; Osteoporosis; Maturation; Medication use; Medication use; Geriatrics; Older patients;
Mounting an attack on the glioblastoma triad : proliferation, invasion and resistanceGooijer M.C. de, PhDBeijnen J.H., prof. dr.Tellingen O. van, dr.Universiteit Utrecht (UU)2019Glioblastoma; Blood-brain barrier; Therapy development; Pharmacology; Cell biology; Combination therapy; Mouse models;
Unintended effects of anti-hyperglycaemic drugs studied in population-based cohortsDriessen J.H.M., PhDBergh J.P.W. van den, prof. dr.Vries F. de, prof. dr.Onzenoort H.A.W. van, PhDUniversiteit Maastricht (UM)2017Hyperglycaemic drugs; Population-based;
Methodological approaches to the pharmacogenomics of statinsPeters B.J.M., dr.Boer A. de, prof. dr.Maitland-van der Zee A.H., prof. dr.Klungel O.H., prof. dr.Universiteit Utrecht (UU)2010Methodology; Statins; Pharmacogenomics;
Challenges in the clinical development of orphan drugsKreeftmeijer-Vegter A.R., PhDBoer A. de, prof. dr.Vries P.J. de, dr.Universiteit Utrecht (UU)2015Orphan drugs; Clinical development; Paediatric formulation; Pharmacokinetics; Efficacy; Safety; Regulatory;
Risk factors and treatment of paediatric chronic diseases - Type 1 diabetes, asthma and allergyAhmadizar F., PhDBoer A. de, prof. dr.Maitland-van der Zee A.H., prof. dr.Universiteit Utrecht (UU)2016Children; Diabetes mellitus; Allergy
Assessing the impact of gout:validating and understanding outcomesSpaetgens B.P.A., drBoonen A.E.R.C.H., prof. dr.Vries F. de, prof. dr.Universiteit Maastricht (UM)2017
Supporting patients : pharmacy based interventions to improve medication adherenceKooij M.J., PhDBouvy M.L., prof. dr.Heerdink E.R., dr.Dijk C.E.M.J. van, dr. ir.Universiteit Utrecht (UU)2015Medication adherence; Pharmacists; Intervention; Pharmacy; Compliance; Community pharmacy;
Readmission to primary care : the role of community pharmacists post-dischargeEnsing H.T., PhDBouvy M.L., prof. dr.Koster E.S., PhDDooren A.A. van, dr.Universiteit Utrecht (UU)2017Safety; Care continuity; Discharge; Pharmacist home visit;
Clinical pharmacological studies in tuberculosis patientsSemvua H.H., PhDBurger D.M., prof. dr.Aarnoutse R.E., dr.Boeree M.J., dr.Radboud Universiteit (RU)2014Clinical pharmacology; Pharmacokinetics; Tuberculosis
Optmizing long-term care for hiv-infected patients in ThailandRamautarsing R.A., PhDBurger D.M., prof. dr.Wit F.W.N.M., dr.Wijgert J.H.H.M. van de, dr.Universiteit van Amsterdam (UvA)2013HIV; clinical pharmacology
Exposure to antiretroviral agents in hiv-infected pregnant women: not too much-not too littleColbers E.P.H., PhDBurger D.M., prof. dr.Radboud Universiteit (RU)2015HIV; antiretroviral agents; clinical pharmacology; drug drug interactions
Making things easier: how to improve antiviral drug treatment for childrenBastiaans D.E.T., dr.Burger D.M., prof. dr.Radboud Universiteit (RU)2016Clinical pharmacology; Antiviral drug treatment;
Early phase clinical drug development for HPV-induced disorders: novel tools and treatmentsRijsbergen M.Burggraaf J., prof. dr.Rissmann R, prof.dr.Poelgeest M.I.E. van, dr.Universiteit Leiden (UL)2020HPV-induced diseases;
Investigations of skin inflammation with a novel dermatology toolbox for early phase clinical drug developmentKolk T. van der, drBurggraaf J., prof. dr.Rissmann R, prof.dr.Universiteit Leiden (UL)2021Skin inflammation Dermatology toolbox Early phase clinical drug development Trial at home Inflammation models Skin microbiome Atopic dermatitis
Rational use of antibioticsDijkmans A.C.Burggraaf J., prof. dr.Universiteit Leiden (UL)2020Antibiotics; Pharmacokinetics;Flucloxacillin;Penicillin; Pheneticillin;Rifampin;Colistin;Fosfomycin
Characterization and re-evaluation of experimental pain models in healthy subjectsSiebenga P.SCohen A.F., prof. dr.Universiteit Leiden (UL)2020Analgesics Human evoked pain models Neuropathic pain Nociceptive pain Pharmacodynamics Phase-1 clinical triala
Measuring pharmacodynamics in early clinical drug studies in multiple sclerosisKanhai K.M.SCohen A.F., prof. dr.Groeneveld G.J., prof. dr.Universiteit Leiden (UL)2019Multiple sclerosis Drug development Biomarkers Remyelination
The Clinical Pharmacology of performance enhancement and doping detection in sportsHeuberger J., dr.Cohen A.F., prof. dr.Groeneveld G.J., prof. dr.Rotmans J.I., dr.Universiteit Leiden (UL)2019Performance enhancement and doping detection in sports
Optimisation of first clinical studies in special populations: towards semi-physiological pharmacokinetics Strougo A., PhDDanhof M., prof. dr.Freijer J., dr.Yassen A., dr.Universiteit Leiden (UL)2015Special-population; Model-based; PK-model; Paediatrics; Children; Hepatic and renal impairment; Semi-physiological; Population approach; PBPK;
Adherence to antiretroviral combination therapy in children : what a difference half a day makes...Piana C., PhDDanhof M., prof. dr.Della Pasqua O.E., dr.Universiteit Leiden (UL)2013Paediatrics; Antiretroviral combination therapy; Compliance; Antiretroviral drugs; Paediatric populations; Drug combinations; Model-based; Covariate analysis; Predictive pharmacokinetic models; Clinical trial simulations; Adherence; Forgiveness of non-adherence;
Pharmacokinetics, pharmacodynamics and safety of different propofol formulationsKnibbe C.A.J., prof. dr.Danhof M., prof. dr.Aarts L.P.H.J., prof. dr.Kuks P.F.M., dr.Universiteit Leiden (UL)2002Pharmacokinetics; Pharmacodynamics; Propofol;
From data to models : reducing uncertainty in benefit risk assessment : application to chronic iron overload in childrenBellanti F., PhDDanhof M., prof. dr.Della Pasqua O.E., dr.Universiteit Leiden (UL)2015Benefit-risk assessment; Paediatrics; Iron chelations; PK-PD modelling; Modelling-&-simulations; Multi-criteria-decision-analysis; Iron-overload; Deferiprone; Deferoxamine;
Novel directions in therapy against age-related vascular diseaseWu H., PhDDanser A.H.J., prof. dr.Roks A.J.M., dr.Erasmus Universiteit Rotterdam (EUR)2014Pharmacology; Cardiovascular disease;
Preeclampsia, the renin-angiotensin-aldosterone system and beyondVerdonk K., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2015Pre-eclampsia; Antihypertensive drugs; Pharmacology; Primary care; Renin-angiotensin system;
New therapeutic targets in cardiovascular disease: focus on the renin-angiotensin system and lipid metabolismSun YDanser A.H.J., prof. dr.Lu X., PhDErasmus Universiteit Rotterdam (EUR)2020Renin-angiotensin system; lipid metabolism; Vascular reactivity; Pharmacology; Treatment options;
The alternative renin-angiotensin system: exploration of its therapeutic potentialSevá Pessôa B., PhDDanser A.H.J., prof. dr.Roks A.J.M., dr.Erasmus Universiteit Rotterdam (EUR)2015Pharmacology; Cardiovascular disease; Renin-angiotensin system;
Natriuretic peptides, diagnostics and prognostic biomarkersRutte J.H.W., dr.Danser A.H.J., prof. dr.Meiracker A.H. van den, dr.Erasmus Universiteit Rotterdam (EUR)2010Antihypertensive drugs; Pharmacology; Kidney; Natriuretic peptides; Renine-angiotensine system;
Vascular Effects of Current and Novel Antimigraine DrugsRubio Beltrán AEDanser A.H.J., prof. dr.Maassen van den Brink A., dr.Erasmus Universiteit Rotterdam (EUR)2019Migraine; Vascular reactivity; Drug efficacy; Pharmacology;
Aortic pathology and the role of the renin-angiotensin systemMolzer E., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2011Pharmacology; Cardiovascular disease; Renin-angiotensin system;
The (pro)renin receptor: moving away from prorenin?Lu X., PhDDanser A.H.J., prof. dr.Meima M.E., dr.Erasmus Universiteit Rotterdam (EUR)2014Cardiovascular disease; Pharmacology; Prorenin;
Hypertension and renal toxicity during angiogenesis inhibition: Salt dependency and treatment optionsLankhorst S.Danser A.H.J., prof. dr.Meiracker A.H. van den, dr.Kappers M.H.W., PhDErasmus Universiteit Rotterdam (EUR)2016Hypertension; Renal function; Treatment options
Neurovascular pharmacology of migraine: epigenetics and sex hormonesLabruijere S., PhDDanser A.H.J., prof. dr.Maassen van den Brink A., dr.Erasmus Universiteit Rotterdam (EUR)2014Pharmacology; Migraine; Epigenetics; Neurovascular pharmacology;
Peripheral Projections of the Trigeminovascular System as Antimigraine TargetLabastida Ramírez ADanser A.H.J., prof. dr.Maassen van den Brink A., dr.Erasmus Universiteit Rotterdam (EUR)2019Migraine; Vascular reactivity; Pharmacology;
(Pro)renin revisited: new insights from studies in mast cellsKrop M., dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2009Cardiovascular disease; Pharmacology; Prorenin;
Cardiovascular, renal and thyroid toxicity during angiogenesis inhibition: a translational approachKappers M.H.W., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2011Cancer; Pharmacology; Antihypertensive drugs;
The role of aldosterone and aldosterone blockade in hypertensionJansen P.M., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2013Cardiovascular disease; Antihypertensive drugs; Pharmacology;
Microvasculature, the Trigeminal System and Migraine: A focus on female sex hormonesIbrahimi K., PhDDanser A.H.J., prof. dr.Maassen van den Brink A., dr.Meiracker A.H. van den, dr.Erasmus Universiteit Rotterdam (EUR)2015Migraine; Microvasculature; Trigeminal System; Female Sex Hormones
The more complex renin-angiotensin system: new insights into an old systemGembardt F., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2011Pharmacology; Renin-angiotensin system;
Unraveling the complexities of the renin-angiotensin system: from ACE to renin inhibitionEsch J.H.M. van, dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2008Cardiovascular disease; Pharmacology; Renin-angiotensin system;
Vascular aging from DNA damage to protectionĎurik M., PhDDanser A.H.J., prof. dr.Roks A.J.M., dr.Erasmus Universiteit Rotterdam (EUR)2012Cardiovascular disease; Pharmacology;
Neurovascular pharmacology of prospective antimigraine drugsChan K.Y., PhDDanser A.H.J., prof. dr.Maassen van den Brink A., dr.Erasmus Universiteit Rotterdam (EUR)2011Pharmacology; Migraine; Neurovascular pharmacology;
Cardiac aldosterone: origin and effectsChai W., dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2005Cardiovascular disease; Pharmacology;
Angiotensin II-induced vasodilation: role of bradykinin, NO and endothelium-derived hyperpolarizing factorsBatenburg W.W., dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2005Cardiovascular disease; Pharmacology;
Determinants of treatment outcomes in epilepsyWassenaar M., PhDEgberts A.C.G., prof. dr.Leijten F.S.S., dr.Uijl S.G., dr.Universiteit Utrecht (UU)2014Epilepsy; Treatment; Treatment outcomes; Quality of life; Patient-perspectives; Clinical determinants; Seizures; Pharmacology; Daily practice; Community-based;
Go to page:
  • of 6